Maat Pharma
MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.
Maat Pharma has raised €25M across 2 funding rounds from 1 investor, most recently a Series B round in Dec 2020. Based in Lyon, France; founded 2014; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€25M
€25,350,000
Funding rounds
2
Investors
1
distinct backers
Active since
2020-05
latest 2020-12
Funding by year
EUR raised per yearMaat Pharma — funding by year — interactive chart.
Data table
| Maat Pharma — funding by year | |
|---|---|
| 2020 | €25M |
Signals
High confidenceRaise-next likelihood8
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-12-02 | Series B | €7.3M | PSIM fund | View deal → |
| 2020-05-02 | Series B | €18M | — | View deal → |
Investors
1Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData